Results 81 to 90 of about 10,569 (220)

COVID-associated neuro-ophthalmopathy. Issues of diagnosis and treatment

open access: yes, 2022
Since the beginning of the COVID-19 pandemic, a large number of reports on extrapulmonary manifestations of the disease have appeared, sometimes focusing on complex cases and challenging diagnostic tasks.
Nikita Yu. Shalkin   +3 more
core  

Prognostic indicators for the development of strabismus among patients with graves’ ophthalmopathy

open access: yesJournal of Clinical & Translational Endocrinology, 2017
Objective: Thyroid eye disease (TED), an autoimmune inflammatory process involving the orbital tissues around the eye, is the most common extra-thyroidal manifestation of Graves’ disease (GD). Due to changes in the patient’s appearance, TED is a socially
Tiffany Y. Lin   +4 more
doaj   +1 more source

Ultrasonic Diagnosis of Graves\u27 Ophthalmopathy

open access: yes, 1990
Precise and reproducible ultrasonographic measurements of the extraocular muscles, particularly the medial, lateral and superior and interior recti, has greatly improved the diagnosis of Graves\u27 ophthalmopathy.
Robert H. Spector
core  

Eye findings and immunological markers in probands and their euthyroid relatives from a single family with multiple cases of thyroid autoimmunity

open access: yesThyroid Research, 2012
Background Ophthalmopathy is a common manifestation of Graves’ disease (GD) occurring in up to 50% of patients. Mild eye signs are also common in patients with Hashimoto’s thyroiditis.
Ardley Melissa   +4 more
doaj   +1 more source

Tear film osmolarity in patients with thyroid ophthalmopathy

open access: yes, 2008
Purpose: To compare tear film osmolarity between patients with thyroid ophthalmopathy and normal healthy ...
Abdula, Arzu   +2 more
core   +1 more source

Thyroid-stimulating immunoglobulins as measured in a reporter bioassay are not detected in patients with Hashimoto’s thyroiditis and ophthalmopathy or isolated upper eyelid retraction

open access: yesClinical Ophthalmology, 2014
Jack R Wall,1 Hooshang Lahooti,1 Ilhem El Kochairi,1 Simon D Lytton,2 Bernard Champion1 1Department of Medicine, the University of Sydney, Penrith, NSW, Australia; 2SeraDiaLogistics, Munich, Germany Abstract: Although ophthalmopathy is mainly ...
Wall JR   +4 more
doaj  

Diagnosis, Follow-Up and Treatment Results in Thyroid Ophthalmopathy

open access: yes, 2015
Objectives: To discuss our follow-up and treatment results in thyroid-associated ophthalmopathy (TAO). Materials and Methods: The records of 168 TAO cases who were followed at our clinic between October 1998 and October 2013 were reviewed ...
Kaan Gündüz   +3 more
core   +1 more source

High-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy.

open access: yes, 1992
We have evaluated the efficacy of high-dose intravenous immunoglobulin treatment in Graves' ophthalmopathy, and have carried out a prospective randomized clinical trial, including a single-blind evaluation, whereby 14 patients were assigned to two ...
Alberti B   +15 more
core   +1 more source

Enfermedades inflamatorias de la úvea Inflammatory diseases of the uvea

open access: yesMedisan, 2010
Se realizó un estudio descriptivo, transversal y prospectivo para determinar las características epidemiológicas de 55 pacientes con enfermedades inflamatorias de la úvea y atendidos en el Servicio de Oftalmología del Hospital Provincial Docente ...
Yudania Fouces Gutiérrez   +3 more
doaj  

Ganoderma lucidum polysaccharide attenuates retinal ischemia-reperfusion injury by regulating microglial M1/M2 polarization, suppressing neuroinflammation and inhibiting JAK2/STAT3 pathway

open access: yesBiochemistry and Biophysics Reports
Retinal ischemia-reperfusion (RIR) injury is implicated in the pathogenesis of numerous retinal degenerative disorders, resulting in visual impairment or even blindness in millions of individuals worldwide.
Guangyu Zhu   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy